JP2004520443A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004520443A5 JP2004520443A5 JP2002590934A JP2002590934A JP2004520443A5 JP 2004520443 A5 JP2004520443 A5 JP 2004520443A5 JP 2002590934 A JP2002590934 A JP 2002590934A JP 2002590934 A JP2002590934 A JP 2002590934A JP 2004520443 A5 JP2004520443 A5 JP 2004520443A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- composition
- agents
- vinyl acetate
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71511700A | 2000-11-20 | 2000-11-20 | |
| PCT/US2001/043111 WO2002094215A2 (en) | 2000-11-20 | 2001-11-16 | Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vimyl acetate as surface stabilizers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009292366A Division JP2010111685A (ja) | 2000-11-20 | 2009-12-24 | 表面安定剤として共重合体を含むナノ粒子組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004520443A JP2004520443A (ja) | 2004-07-08 |
| JP2004520443A5 true JP2004520443A5 (https=) | 2005-12-22 |
| JP4541647B2 JP4541647B2 (ja) | 2010-09-08 |
Family
ID=24872726
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002590934A Expired - Fee Related JP4541647B2 (ja) | 2000-11-20 | 2001-11-16 | 表面安定剤として共重合体を含むナノ粒子組成物 |
| JP2009292366A Pending JP2010111685A (ja) | 2000-11-20 | 2009-12-24 | 表面安定剤として共重合体を含むナノ粒子組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009292366A Pending JP2010111685A (ja) | 2000-11-20 | 2009-12-24 | 表面安定剤として共重合体を含むナノ粒子組成物 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1341521B1 (https=) |
| JP (2) | JP4541647B2 (https=) |
| AT (1) | ATE419834T1 (https=) |
| AU (1) | AU2001297844A1 (https=) |
| CA (1) | CA2428785C (https=) |
| DE (1) | DE60137362D1 (https=) |
| ES (1) | ES2317874T3 (https=) |
| WO (1) | WO2002094215A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7101576B2 (en) * | 2002-04-12 | 2006-09-05 | Elan Pharma International Limited | Nanoparticulate megestrol formulations |
| US9101540B2 (en) | 2002-04-12 | 2015-08-11 | Alkermes Pharma Ireland Limited | Nanoparticulate megestrol formulations |
| US20100297252A1 (en) | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
| US8512727B2 (en) | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
| CN101094659A (zh) * | 2004-12-31 | 2007-12-26 | 伊休蒂卡有限公司 | 纳米微粒组合物及其合成方法 |
| EA200702595A1 (ru) * | 2005-05-23 | 2008-12-30 | Элан Фарма Интернэшнл Лимитед | Композиции контролируемого высвобождения в форме наночастиц, содержащие ингибитор агрегации тромбоцитов |
| WO2007046632A1 (en) * | 2005-10-18 | 2007-04-26 | Amorepacific Corporation | Cationic polymer nanoparticles encapsulating an active ingredients, and the cosmetic composition containing the same |
| WO2008002485A2 (en) * | 2006-06-23 | 2008-01-03 | Alza Corporation | Increased amorphous stability of poorly water soluble drugs by nanosizing |
| AU2016203251B2 (en) * | 2006-06-30 | 2017-11-16 | Iceutica Pty Ltd | Methods for the Preparation of Biologically Active Compounds in Nanoparticle Form |
| DK2054042T3 (da) * | 2006-06-30 | 2020-08-03 | Iceutica Pty Ltd | Fremgangsmåder til fremstilling af biologisk aktive forbindelser i nanopartikelform |
| US20090311335A1 (en) * | 2008-06-12 | 2009-12-17 | Scott Jenkins | Combination of a triptan and an nsaid |
| AU2010239081C1 (en) | 2009-04-24 | 2014-11-06 | Iceutica Pty Ltd | A novel formulation of indomethacin |
| MY165826A (en) * | 2010-10-01 | 2018-05-17 | Cipla Ltd | Pharmaceutical composition |
| WO2013125232A1 (ja) * | 2012-02-23 | 2013-08-29 | キヤノン株式会社 | 光音響造影剤用色素含有ナノ粒子 |
| US9526734B2 (en) | 2014-06-09 | 2016-12-27 | Iceutica Pty Ltd. | Formulation of meloxicam |
| US10022328B2 (en) | 2015-02-20 | 2018-07-17 | Cytec Industries Inc. | Dialkyl sulfosuccinate compositions, method of making, and method of use |
| JP7021182B2 (ja) * | 2016-03-24 | 2022-02-16 | ロケート・バイオ・リミテッド | 足場材料、方法および使用 |
| GB201810925D0 (en) * | 2018-07-03 | 2018-08-15 | Blueberry Therapeutics Ltd | Compositions and methods of treatment |
| PL3928772T3 (pl) | 2020-06-26 | 2024-10-07 | Algiax Pharmaceuticals Gmbh | Kompozycja nanocząstkowa |
| CA3207235A1 (en) * | 2021-01-11 | 2022-07-14 | Bayer Healthcare Llc | Concentrated liquid gel formulations containing naproxen salts |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2608988B1 (fr) * | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules |
| GB9200607D0 (en) * | 1992-01-13 | 1992-03-11 | Ethical Pharma Ltd | Pharmaceutical compositions containing nifedipine and process for the preparation thereof |
| FR2698560B1 (fr) * | 1992-11-30 | 1995-02-03 | Virbac Laboratoires | Principes actifs pulvérulents stabilisés, compositions les contenant, leur procédé d'obtention et leurs applications. |
| US5336507A (en) * | 1992-12-11 | 1994-08-09 | Sterling Winthrop Inc. | Use of charged phospholipids to reduce nanoparticle aggregation |
| US5326552A (en) * | 1992-12-17 | 1994-07-05 | Sterling Winthrop Inc. | Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants |
| DE59709127D1 (de) * | 1996-07-08 | 2003-02-20 | Ciba Sc Holding Ag | Triazinderivate als UV-Filter in Sonnenschutzmitteln |
| RU2186562C2 (ru) * | 1996-08-22 | 2002-08-10 | Ресеч Трайангл Фармасьютикалс Лтд. | Композиции, представляющие собой микрочастицы веществ, нерастворимых в воде, и способ их изготовления |
| US6045829A (en) * | 1997-02-13 | 2000-04-04 | Elan Pharma International Limited | Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
| WO2000018374A1 (en) * | 1998-10-01 | 2000-04-06 | Elan Pharma International, Ltd. | Controlled release nanoparticulate compositions |
| US6375986B1 (en) * | 2000-09-21 | 2002-04-23 | Elan Pharma International Ltd. | Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
-
2001
- 2001-11-16 AT AT01274072T patent/ATE419834T1/de not_active IP Right Cessation
- 2001-11-16 ES ES01274072T patent/ES2317874T3/es not_active Expired - Lifetime
- 2001-11-16 JP JP2002590934A patent/JP4541647B2/ja not_active Expired - Fee Related
- 2001-11-16 WO PCT/US2001/043111 patent/WO2002094215A2/en not_active Ceased
- 2001-11-16 DE DE60137362T patent/DE60137362D1/de not_active Expired - Lifetime
- 2001-11-16 AU AU2001297844A patent/AU2001297844A1/en not_active Abandoned
- 2001-11-16 EP EP01274072A patent/EP1341521B1/en not_active Expired - Lifetime
- 2001-11-16 CA CA2428785A patent/CA2428785C/en not_active Expired - Lifetime
-
2009
- 2009-12-24 JP JP2009292366A patent/JP2010111685A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004520443A5 (https=) | ||
| US6969529B2 (en) | Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers | |
| JP2010111685A (ja) | 表面安定剤として共重合体を含むナノ粒子組成物 | |
| JP5191073B2 (ja) | ナノ粒子組成物における結晶成長および粒子凝集を防止するための方法 | |
| JP6534979B2 (ja) | 低溶解性化合物の安定な複合体 | |
| JP4623966B2 (ja) | 表面安定剤としてチロキサポールを含有する、濾過滅菌したブデソニドおよびベクロメタゾンのナノ粒子製剤 | |
| JP4380925B2 (ja) | ナノパーティクル組成物用の表面安定剤としてのｐｅｇ誘導体化脂質の使用 | |
| US5534270A (en) | Method of preparing stable drug nanoparticles | |
| AU2005307797B2 (en) | Injectable nanoparticulate olanzapine formulations | |
| JP2005536512A5 (https=) | ||
| JP2011006450A (ja) | 非晶質シクロスポリンを含んで成るナノ粒状組成物並びに当該組成物の製造方法及び使用方法 | |
| TW201808273A (zh) | 具有改善的藥物動力學的控釋γ-羥基丁酸鹽調配物 | |
| JP2006514688A5 (https=) | ||
| CN101237868A (zh) | 纳米粒氯吡格雷和阿司匹林组合制剂 | |
| JP2008524239A (ja) | ナノ粒子のタクロリムス製剤 | |
| JP2005508939A5 (https=) | ||
| CN1246058A (zh) | 包含环孢菌素a的无油药物组合物 | |
| JP2010516704A (ja) | 摂食／絶食による変動性を低減し、かつ経口バイオアベイラビリティーを改善するための難水溶性薬物の多相医薬製剤 | |
| JP2018517734A (ja) | デフェラシロクスの改善された製剤およびその作製方法 | |
| MX2007012762A (es) | Composiciones de material nanoparticulado y de liberacion controlada que comprende ciclosporina. | |
| JP2009518300A (ja) | モメタゾン組成物ならびにその作製方法および使用方法 | |
| JP4865990B2 (ja) | ナノ粒子メゲストロール製剤 | |
| WO2023240094A1 (en) | Amorphous dosage form containing ebselen | |
| MXPA99012099A (en) | Gelatine encapsulated solution dosage forms of sertraline |